<div>Researchers in the United States have conducted a pre-clinical study demonstrating the efficacy of two updated versions of the Moderna mRNA-1273 vaccine against variants of severe acute respiratory syndrome coronavirus 2 &ndash; the agent that causes coronavirus disease 2019 (COVID-19).</div>